Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04XEO
|
|||
| Former ID |
DIB012965
|
|||
| Drug Name |
ChelASE
|
|||
| Synonyms |
VitrenASE; VIT-100
Click to Show/Hide
|
|||
| Indication | Retina disorder [ICD-11: 9B70-9B7Z] | Discontinued in Phase 1 | [1] | |
| Company |
Immusol
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017704) | |||
| REF 2 | Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. Arch Ophthalmol. 2007 Sep;125(9):1161-7. | |||
| REF 3 | Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells. PLoS One. 2013 Jul 31;8(7):e70430. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.